A00705 Summary:

BILL NOA00705B
 
SAME ASSAME AS S06746-A
 
SPONSORRosenthal L
 
COSPNSR
 
MLTSPNSR
 
Add §32.12, Ment Hyg L
 
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.
Go to top    

A00705 Actions:

BILL NOA00705B
 
01/06/2021referred to alcoholism and drug abuse
05/13/2021amend and recommit to alcoholism and drug abuse
05/13/2021print number 705a
05/24/2021reported referred to ways and means
01/05/2022referred to ways and means
04/27/2022amend and recommit to ways and means
04/27/2022print number 705b
Go to top

A00705 Committee Votes:

ALCOHOLISM AND DRUG ABUSE Chair:Steck DATE:05/24/2021AYE/NAY:14/0 Action: Favorable refer to committee Ways and Means
SteckAyeBrownAye
QuartAyeDeStefanoAye
StirpeAyeDursoAye
DavilaAyeGandolfoAye
McDonaldAye
FernandezAye
GriffinAye
ReyesAye
GallagherAye
JacksonAye

Go to top

A00705 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A00705 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A705B
 
SPONSOR: Rosenthal L
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to the availability of buprenorphine in opioid treatment programs   PURPOSE: This bill relates to the availability of buprenorphine in opioid treat- ment programs.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends the mental hygiene law by adding a new section 32.12. Section two establishes the effective date.   JUSTIFICATION: New York State is working to build out a comprehensive harm reduction infrastructure to combat the opioid epidemic, with the goal of making treatment available on demand to people in every region. While the state works to diversify the treatment models it supports, we must ensure that the gold standard of harm reduction treatment - access to buprenorphine - is offered at every opioid treatment program statewide. This legislation requires that all providers of chemical dependence services have at least one practitioner on staff that is able to admin- ister buprenorphine. The most critical objective of any treatment facil- ity is keeping their patients alive, and guaranteed access to buprenor- phine is a vital step in achieving this goal.   LEGISLATIVE HISTORY: 2019-20: A3953 - Referred to Alcoholism and Drug Abuse   FISCAL IMPLICATIONS: Undetermined.   EFFECTIVE DATE: This act shall take effect on the one Hundred twentieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Go to top

A00705 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         705--B
 
                               2021-2022 Regular Sessions
 
                   IN ASSEMBLY
 
                                       (Prefiled)
 
                                     January 6, 2021
                                       ___________
 
        Introduced  by  M.  of  A. L. ROSENTHAL -- read once and referred to the
          Committee on Alcoholism and Drug Abuse -- committee  discharged,  bill
          amended,  ordered reprinted as amended and recommitted to said commit-
          tee -- reported and referred to the Committee on  Ways  and  Means  --
          recommitted  to  the  Committee  on  Ways and Means in accordance with
          Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered
          reprinted as amended and recommitted to said committee
 
        AN ACT to amend the mental hygiene law, in relation to the  availability
          of buprenorphine in opioid treatment programs
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The mental hygiene law is amended by adding a  new  section
     2  32.12 to read as follows:
     3  § 32.12 Availability of buprenorphine.
     4    Every   facility  licensed  or  authorized  to  provide  services  for
     5  substance use disorders related to  opioids  that  employs  a  qualified
     6  practitioner,  as  determined  by federal law, shall ensure at least one
     7  practitioner in the facility has received an appropriate  waiver  and/or
     8  has completed required training to administer or prescribe buprenorphine
     9  to  individuals  in  their care with a substance use disorder where such
    10  drug is determined appropriate for their treatment.
    11    § 2. This act shall take effect on the one hundred twentieth day after
    12  it shall have become a law.  Effective immediately, the addition, amend-
    13  ment and/or repeal of any rule or regulation necessary for the implemen-
    14  tation of this act on its effective date are authorized to be  made  and
    15  completed on or before such effective date.
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00547-06-2
Go to top